select trial semaglutide cardiovascular outcomes non-diabetic 2023 align more closely with attained dose than achieved weight loss Lower risk of cardiovascular events

Important limitations remain Despite the encouraging findings, the study has several limitations typical of retrospective analyses

Peptides and GLP-1 medications work differently

Generic versions of Novo Nordisks blockbuster Wegovy and Ozempic medications could be mass produced for about $3 per person per month, a cost that could greatly widen access in low- and middle-income countries, according to a new analysis

Some medical conditions and medications work best when combined with daily healthy habits and consistency

or/8-12 14

Supplement use should complement, not replace, clinical assessment of antioxidant status and underlying health conditions